(Q33732945)

29 July 2017

1 reference

title

Transplantation tolerance: the concept and its applicability (English)

1 reference

29 July 2017

Dong VM

1

1 reference

PubMed ID

10487277

29 July 2017

Womer KL

series ordinal

2

1 reference

PubMed ID

10487277

29 July 2017

Sayegh MH

series ordinal

3

1 reference

29 July 2017

1 August 1999

1 reference

Pediatric Transplantation

29 July 2017

1 reference

29 July 2017

3

1 reference

29 July 2017

181-192

1 reference

29 July 2017

3

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

29 July 2017

1 reference

Immunosuppressive strategies in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Transplantation tolerance: fooling mother nature

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Actively acquired tolerance of foreign cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

The role of T-cell costimulatory activation pathways in transplant rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Homeostasis and self-tolerance in the immune system: turning lymphocytes off.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

T-cell antigen receptor genes and T-cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

T Cell Reactivity to MHC Molecules: Immunity Versus Tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

The role of the T cell receptor in positive and negative selection of developing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Cellular interactions in thymocyte development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

CTLA-4 is a second receptor for the B cell activation antigen B7

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

CTLA-4 can function as a negative regulator of T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

CTLA-4 ligation blocks CD28-dependent T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

CTLA-4: a negative regulator of autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

"Infectious" transplantation tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Cytokines and the Th1/Th2 paradigm in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Balancing the immune system for tolerance: a case for regulatory CD4 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Induction of tolerance by intrathymic inoculation of alloantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Indirect presentation of MHC antigens in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Indirect T-cell allorecognition: perspectives for peptide-based therapy in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Gene therapy and allotransplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

CD40 and its ligand in host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

The molecular basis for T cell help in humoral immunity: CD40 and its ligand, gp39.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Finally, CTLA4Ig graduates to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

T cell tolerance by clonal elimination in the thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

21 January 2018

2 references

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

21 January 2018

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

7 January 2021

Renal transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

7 January 2021

Transplantation tolerance

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

7 January 2021

Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

7 January 2021

A cell culture model for T lymphocyte clonal anergy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

7 January 2021

In vivo mechanisms of acquired thymic tolerance

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

7 January 2021

T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

7 January 2021

Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

7 January 2021

Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

7 January 2021

High-dose donor bone marrow infusions to enhance allograft survival: the effect of timing

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

7 January 2021

Mechanisms of T cell recognition of alloantigen. The role of peptides

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

7 January 2021

Peptide-mediated immunosuppression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

7 January 2021

Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

7 January 2021

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

7 January 2021

The use of monoclonal antibodies to achieve immunological tolerance

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

7 January 2021

Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

7 January 2021

CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

7 January 2021

CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

7 January 2021

Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.1999.00042.X

7 January 2021

10.1034/J.1399-3046.1999.00042.X

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10487277